shire map
Select a

Shire Global


Shire to participate at two upcoming investor conferences

Lexington, MA, USA – June 3, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Jeff Poulton, Chief Financial Officer, will present at the Goldman Sachs 37th Annual Global Healthcare Conference on June 8, 2016 at 10:40 a.m. PDT (6:40 p.m. BST) and Perry Sternberg, Head of US Commercial will present at the Jefferies 2016 Healthcare Conference on June 9, 2016 at 11:30 a.m. EDT (4:30 p.m. BST).

The live audio webcasts of both events will be available on the Presentations and Webcasts section of Shire's Investor website at Subsequently, a replay of both events will be available on this same website.

For further information please contact:

Investor Relations  
Sarah 1256 894157
Ian 781 482 9018
Robert 1256 894874


Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We have best-in-class products available in more than 100 countries across core therapeutic areas including Hematology, Immunology, Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.


Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE